Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-section
Tau PET imaging has emerged as a critical biomarker for Alzheimer's disease, informing diagnosis, staging, and therapeutic selection. We investigated whether PET tracer selection alters tau detection. We conducted a prospective, multicentre, non-randomised, within-participan
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.